Hempnewsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues To Strengthen Executive Team In Anticipation Of 'Strong Growth' Into 2025

(MENAFN- Investor Brand Network) Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, has appointed Michael Shankman, CPA, as Chief financial Officer (“CFO”) effective immediately. Mr. Shankman is deeply familiar with Lexaria, having previously worked with the company and assisted with its financial reporting and 2023 audit as a designated contractor. He has previously held financial leadership positions in various industries, including biotechnology, medical devices, and software-as-a-service.

“Mike is an accomplished individual who brings a wealth of financial and regulatory knowledge and experience to the table,” said Richard Christopher, CEO of Lexaria.“On behalf of the entire Lexaria team, I'm thrilled to welcome Mike as our CFO as we continue to strengthen our executive team in expectations of strong growth into 2025.”

To view the full press release, visit

About Lexaria Bioscience Corp.

DehydraTECH(TM) is Lexaria's patented drug delivery formulation and processing platform technology that improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria holds a robust intellectual property portfolio with 46 patents granted and many patents pending worldwide. For more information, visit the company's website at .

NOTE TO INVESTORS : The latest news and updates relating to LEXX are available in the company's newsroom at

About HempWire

HempWire
(“HW”) is a specialized communications platform with a focus on hemp-related news, information, and the latest developments in the hemp sector.
HempWire
is one of 60+ brands within
the
Dynamic Brand Portfolio
@
IBN
that delivers :
(1) access to a vast network of wire solutions via
InvestorWire
to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;
(2) article and
editorial syndication to 5,000+ outlets ;
(3) enhanced
press release enhancement
to ensure maximum impact ;
(4)
social media distribution
via IBN to millions of social media followers ;
and (5) a full array of tailored
corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, HW brings its clients unparalleled recognition and brand awareness. HW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from HempWire, text“HempWire” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published:
/Disclaimer

HempWire
Denver, Colorado

303.498.7722 Office
[email protected]

HempWire is powered by
IBN

MENAFN01102024000224011066ID1108735910